Treatment response appeared to be higher in patients with SARD and elevated inflammatory markers, however, this did not reach statistical significance (OR 2.05 [0.81–5.14], P = 0.125).
← all excerpts
Serum inflammatory markers as predictors of therapeutic response in non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease: a retrospective cohort analysis.
1
0.1250
0.1250